 | Arbutus Biopharma (NASDAQ:ABUS) Now Covered by Jefferies Financial Group marketbeat.com - February 25 at 7:54 AM |
 | Arbutus Biopharma (NASDAQ:ABUS) Trading 5.1% Higher americanbankingnews.com - March 5 at 8:48 PM |
 | Arbutus Biopharma (NASDAQ:ABUS) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS americanbankingnews.com - March 5 at 10:54 AM |
 | Arbutus Biopharma (NASDAQ:ABUS) Shares Down 13.7% americanbankingnews.com - March 4 at 9:35 PM |
 | Recap: Arbutus Biopharma Q4 Earnings benzinga.com - March 4 at 9:07 AM |
 | Arbutus Biopharma Corp. to Host Earnings Call finance.yahoo.com - March 4 at 9:07 AM |
 | Arbutus Reports Fourth Quarter and Year End 2020 Financial Results and Provides Corporate Update finance.yahoo.com - March 4 at 9:07 AM |
 | Earnings Preview: Arbutus Biopharma finance.yahoo.com - March 3 at 5:59 PM |
 | Is a Surprise Coming for Arbutus Biopharma (ABUS) This Earnings Season? finance.yahoo.com - March 3 at 12:58 PM |
 | Zacks: Analysts Expect Arbutus Biopharma Co. (NASDAQ:ABUS) to Announce -$0.23 EPS americanbankingnews.com - March 2 at 10:14 PM |
|
 | Arbutus to Participate at H.C. Wainwright Global Life Sciences Conference finance.yahoo.com - March 2 at 9:55 AM |
 | Arbutus Biopharma (NASDAQ:ABUS) Coverage Initiated at Jefferies Financial Group americanbankingnews.com - February 25 at 9:02 AM |
 | Arbutus Biopharma (ABUS) to Release Earnings on Thursday americanbankingnews.com - February 25 at 2:10 AM |
 | Arbutus Biopharma (NASDAQ:ABUS) Trading 15.4% Higher americanbankingnews.com - February 24 at 7:20 PM |
 | Arbutus Biopharma (NASDAQ:ABUS) Stock Price Down 10.7% americanbankingnews.com - February 23 at 8:32 PM |
 | Arbutus to Report Fourth Quarter and Year End 2020 Financial Results and Provide Corporate Update finance.yahoo.com - February 22 at 9:00 AM |
 | Arbutus Biopharma Co. (NASDAQ:ABUS) Receives Consensus Rating of "Buy" from Analysts americanbankingnews.com - February 19 at 9:10 AM |
 | Here's What Arbutus Biopharma Corporation's (NASDAQ:ABUS) Shareholder Ownership Structure Looks Like finance.yahoo.com - February 15 at 9:40 AM |
 | ABUS Feb 2021 5.000 call uk.finance.yahoo.com - January 26 at 7:18 PM |
 | Arbutus: A Promising Pure-Play On The $2.13 Billion Global Hepatitis B Market seekingalpha.com - January 26 at 7:18 PM |
 | Arbutus Announces 2021 Corporate Objectives and Provides Financial Update finance.yahoo.com - January 25 at 8:42 AM |
 | ABUS Feb 2021 7.500 call uk.finance.yahoo.com - January 23 at 7:01 PM |
 | ABUS Jan 2021 10.000 put uk.finance.yahoo.com - January 13 at 11:02 PM |
 | Arbutus to Participate in Virtual Fireside Chat at H.C. Wainwright BioConnect 2021 Conference finance.yahoo.com - January 4 at 8:30 AM |
 | Are Investors Undervaluing Arbutus Biopharma Corporation (NASDAQ:ABUS) By 26%? finance.yahoo.com - January 1 at 8:24 AM |
 | Why Transdermal Drug Delivery Systems are Outweighing Advantages of Traditional Methods marketwatch.com - December 15 at 12:35 PM |
 | Is ABUS A Good Stock To Buy Now? finance.yahoo.com - December 12 at 6:59 PM |
 | Thinking about buying stock in Pfizer, Rewalk Robotics, Veru, Arbutus Biopharma, or Plug Power? marketwatch.com - December 10 at 2:30 PM |
 | Arbutus Announces Robust HBsAg Decline Data with AB-729 Dosed at 60 mg Every 8 Weeks in Chronic Hepatitis B Subjects finance.yahoo.com - December 10 at 2:30 PM |
 | ABUS Dec 2020 10.000 put au.finance.yahoo.com - November 29 at 4:15 PM |
 | Arbutus' AB-729 shows encouraging results in chronic hepatitis B seekingalpha.com - November 16 at 10:01 AM |
 | Arbutus Announces Additional Robust HBsAg Decline Data with AB-729 in Chronic Hepatitis B Subjects finance.yahoo.com - November 16 at 10:01 AM |
|
 | Implied Volatility Surging for Arbutus Biopharma (ABUS) Stock Options finance.yahoo.com - November 12 at 1:49 PM |
 | Arbutus to Present at Jefferies Virtual London Healthcare Conference finance.yahoo.com - November 10 at 9:00 AM |
 | Earnings Update: Arbutus Biopharma Corporation (NASDAQ:ABUS) Just Reported And Analysts Are Trimming Their Forecasts nasdaq.com - November 7 at 12:18 PM |
 | Arbutus Biopharma Corporation (NASDAQ:ABUS) Analysts Are Cutting Their Estimates: Here's What You Need To Know finance.yahoo.com - November 7 at 7:17 AM |
 | Arbutus Biopharma Corporation (ABUS) CEO Bill Collier on Q3 2020 Results - Earnings Call Transcript seekingalpha.com - November 5 at 5:29 PM |
 | Arbutus Biopharma EPS misses by $0.05, misses on revenue seekingalpha.com - November 5 at 12:29 PM |
 | Return On Capital Employed Overview: Arbutus Biopharma benzinga.com - November 4 at 11:26 AM |
 | We're Keeping An Eye On Arbutus Biopharma's (NASDAQ:ABUS) Cash Burn Rate finance.yahoo.com - October 16 at 2:13 PM |
 | Arbutus to Participate in Virtual Fireside Chat at Chardan's 4th Annual Genetic Medicines Conference marketwatch.com - September 28 at 11:27 PM |
 | Thinking about buying stock in Arbutus Biopharma, TRACON Pharmaceuticals, Workhorse Group, Trevena, or Cassava Sciences? marketwatch.com - September 17 at 5:43 PM |
 | Why Arbutus Stock Is Trading Higher Today msn.com - September 15 at 12:25 PM |
 | Arbutus' AB-729 shows positive action in HBV study seekingalpha.com - September 15 at 12:25 PM |
 | Bucks County firm's stock surges on positive study data for hepatitis B therapy bizjournals.com - September 15 at 12:25 PM |
 | Arbutus Announces AB-729 90 mg Single-Dose Week 12 Data in Chronic Hepatitis B Subjects Demonstrating Significant and Continuous Reductions in HBsAg finance.yahoo.com - September 15 at 12:25 PM |
 | Arbutus to Participate in Virtual Fireside Chat at H.C. Wainwright 22nd Annual Global Investment Conference finance.yahoo.com - September 9 at 9:15 AM |
 | As CDC Issues Notice, Stock Market Bets Which Company Gets First COVID-19 Vaccine FDA Approval msn.com - September 4 at 6:15 PM |
 | Ebola Treatment Market Analysis and Global Research Report 2020 to 2026 marketwatch.com - August 28 at 4:59 AM |
 | Assembly Biosciences teams up with Arbutus Biopharma in chronic HBV infection seekingalpha.com - August 27 at 8:49 AM |
 | Assembly Biosciences and Arbutus Biopharma Announce Clinical Collaboration Agreement to Evaluate the Combination of Core Inhibitor ABI-H0731 with RNAi Therapeutic AB-729 in Patients with Chronic Hepatitis B Virus Infection finance.yahoo.com - August 27 at 8:49 AM |